Number To Know…9
Executive Summary
Dignitana, of Lund, Sweden, is expanding the US presence of its DigniCap scalp cooling device with 9 additional installations.
9 is the number of new installations of DigniCap scalp cooling device, designed to reduce chemotherapy-induced hair loss, in medical centers across the US. DigniCap is the product of Swedish firm Dignitana and is said to be “the first scalp cooling device to complete rigorous FDA clinical trials in America, where seven out of ten patients with early-stage breast cancer kept at least 50% of their hair.” The device was cleared by the US FDA in December 2015 for use in breast cancer patients undergoing chemotherapy. The latest installations, announced on Feb.22, bring DigniCap’s installed base in the US to 57 medical centers.
Meddevicetracker subscribers can access a full analysis of DigniCap and how it works here.
Not a subscriber, click here to request your free demo.